Apogee Therapeutics (APGE) News Today $39.48 -0.88 (-2.18%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$39.45 -0.03 (-0.08%) As of 05/23/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock APGE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Brokerages Set Apogee Therapeutics, Inc. (NASDAQ:APGE) PT at $94.60May 25 at 1:13 AM | americanbankingnews.comApogee Therapeutics, Inc. (NASDAQ:APGE) Given Average Rating of "Buy" by BrokeragesShares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Get Free Report) have received an average recommendation of "Buy" from the five analysts that are presently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a buy recommendation. The average 12 month pMay 24 at 11:22 AM | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Shares Bought by Woodline Partners LPWoodline Partners LP grew its holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 4.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,015,608 shares of the company's stock after buying an additional 39,May 22 at 6:18 AM | marketbeat.comSoleus Capital Management L.P. Invests $3.17 Million in Apogee Therapeutics, Inc. (NASDAQ:APGE)Soleus Capital Management L.P. bought a new position in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 70,000 shares of the company's stock, valued at approximately $3May 21, 2025 | marketbeat.comPoint72 Asset Management L.P. Lowers Stake in Apogee Therapeutics, Inc. (NASDAQ:APGE)Point72 Asset Management L.P. reduced its holdings in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 57.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 302,735 shares of the companMay 20, 2025 | marketbeat.comNorthern Trust Corp Grows Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE)Northern Trust Corp increased its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 6.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 327,292 shares of the company's stock after purchaMay 18, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Shares Bought by Paradigm Biocapital Advisors LPParadigm Biocapital Advisors LP raised its holdings in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 82.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,283,766May 16, 2025 | marketbeat.comParkman Healthcare Partners LLC Buys Shares of 85,000 Apogee Therapeutics, Inc. (NASDAQ:APGE)Parkman Healthcare Partners LLC bought a new position in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 85,000 shares of the company's stock, valueMay 16, 2025 | marketbeat.comWedbush Research Analysts Boost Earnings Estimates for APGEApogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) - Analysts at Wedbush increased their Q2 2025 earnings per share estimates for shares of Apogee Therapeutics in a note issued to investors on Monday, May 12th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings oMay 16, 2025 | marketbeat.comJanus Henderson Group PLC Buys 665,543 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE)Janus Henderson Group PLC grew its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 141.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,135,100 shares of the company's stock after acMay 16, 2025 | marketbeat.comQ2 EPS Estimates for Apogee Therapeutics Raised by WedbushMay 16, 2025 | americanbankingnews.comEquities Analysts Offer Predictions for APGE Q1 EarningsApogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) - Investment analysts at Wedbush issued their Q1 2026 earnings estimates for shares of Apogee Therapeutics in a research report issued to clients and investors on Monday, May 12th. Wedbush analyst D. Nierengarten expects that the company willMay 15, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Holdings Cut by Comerica BankComerica Bank trimmed its stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 26.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 20,540 shares of the company's stock after selling 7,518 shares duriMay 15, 2025 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Issues Quarterly Earnings Results, Beats Expectations By $0.24 EPSApogee Therapeutics (NASDAQ:APGE - Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.95) EPS for the quarter, beating the consensus estimate of ($1.19) by $0.24.May 14, 2025 | marketbeat.comJefferies Financial Group Inc. Boosts Stake in Apogee Therapeutics, Inc. (NASDAQ:APGE)Jefferies Financial Group Inc. increased its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 140.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 887,497 shares of the company's stock after purchasing anMay 13, 2025 | marketbeat.comWhy Is Apogee Therapeutics Stock Trading Higher On Monday?May 13, 2025 | finance.yahoo.comApogee Therapeutics: APG808 Asthma Treatment May Overtake Dupixent In IL-4Rα ClassMay 13, 2025 | seekingalpha.comApogee Therapeutics reports positive results from asthma treatment trialMay 13, 2025 | msn.comApogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial ResultsMay 12, 2025 | globenewswire.comApogee Therapeutics Announces Positive Interim Results from the Phase 1b Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody, in Patients with Mild-to-Moderate AsthmaMay 12, 2025 | globenewswire.comApogee Therapeutics, Inc. (NASDAQ:APGE) Shares Sold by Frontier Capital Management Co. LLCFrontier Capital Management Co. LLC reduced its stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 44.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 172,711 shares of the company's stock afMay 12, 2025 | marketbeat.comCubist Systematic Strategies LLC Has $4.13 Million Stake in Apogee Therapeutics, Inc. (NASDAQ:APGE)Cubist Systematic Strategies LLC lifted its holdings in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 8.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 91,213 shares of the company's stock after purcMay 12, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Has $3.98 Million Stake in Apogee Therapeutics, Inc. (NASDAQ:APGE)The Manufacturers Life Insurance Company raised its holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 29.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 87,953 shares of the company's stock after buying anMay 11, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Shares Bought by Driehaus Capital Management LLCDriehaus Capital Management LLC lifted its stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 2.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,605,310 shares of the company's sMay 10, 2025 | marketbeat.comCarl Dambkowski Sells 2,725 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) StockMay 10, 2025 | insidertrades.comApogee Therapeutics, Inc. (NASDAQ:APGE) Shares Sold by Braidwell LPBraidwell LP reduced its holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 6.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,540,362 shares of the company's stock after selling 102,864 shares during theMay 8, 2025 | marketbeat.comApogee Therapeutics (APGE) to Release Quarterly Earnings on MondayApogee Therapeutics (NASDAQ:APGE) will be releasing its Q1 2025 earnings before the market opens on Monday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-12-apogee-therapeutics-inc-stock/)May 7, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Purchases Shares of 70,766 Apogee Therapeutics, Inc. (NASDAQ:APGE)Schonfeld Strategic Advisors LLC acquired a new position in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 70,766 shares of the company's stock, valued at approximately $3May 6, 2025 | marketbeat.comVoya Investment Management LLC Decreases Stock Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE)Voya Investment Management LLC cut its holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 18.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 45,960 shares of the company's stock after selling 10,557 sMay 6, 2025 | marketbeat.comAllostery Investments LP Takes $4.53 Million Position in Apogee Therapeutics, Inc. (NASDAQ:APGE)Allostery Investments LP bought a new position in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 100,000 shares of the company's stock, valued at approximately $4,530,0May 4, 2025 | marketbeat.com86,000 Shares in Apogee Therapeutics, Inc. (NASDAQ:APGE) Purchased by Boxer Capital Management LLCBoxer Capital Management LLC acquired a new stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 86,000 shares of the company's stock, valued atMay 4, 2025 | marketbeat.comMercer Global Advisors Inc. ADV Makes New Investment in Apogee Therapeutics, Inc. (NASDAQ:APGE)Mercer Global Advisors Inc. ADV acquired a new position in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 720,101 shares of the company's stock, valued at appMay 4, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Holdings Lowered by Invesco Ltd.Invesco Ltd. lowered its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 83.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,256 shares of the company's stock after selling 110,9May 4, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Stock Holdings Decreased by RA Capital Management L.P.RA Capital Management L.P. lessened its position in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 20.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,569,491 shares of the company's stock after selling 392,372 shaMay 3, 2025 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Hits New 12-Month High - Here's WhyApogee Therapeutics (NASDAQ:APGE) Hits New 1-Year High - Here's What HappenedMay 3, 2025 | marketbeat.comWells Fargo & Company MN Lowers Stock Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE)Wells Fargo & Company MN lowered its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 82.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 17,705 shares of the company's stock after selling 80,585 shares durMay 3, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Stock Position Boosted by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD raised its stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 38.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,052,595 shares of the company's sMay 2, 2025 | marketbeat.comApogee Therapeutics to Participate at the Bank of America 2025 Health Care ConferenceMay 1, 2025 | globenewswire.comAdage Capital Partners GP L.L.C. Buys Shares of 240,200 Apogee Therapeutics, Inc. (NASDAQ:APGE)Adage Capital Partners GP L.L.C. purchased a new position in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 240,200 shares of the company's stock, valued at aApril 30, 2025 | marketbeat.comMarshall Wace LLP Purchases 72,174 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE)Marshall Wace LLP lifted its holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 1,963.9% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 75,849 shares of the company's stock after purchasing an additional 72April 28, 2025 | marketbeat.comJPMorgan Chase & Co. Has $1.69 Million Position in Apogee Therapeutics, Inc. (NASDAQ:APGE)JPMorgan Chase & Co. increased its holdings in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 26.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 37,255 shares of the company's stock after purchasing an additional 7,700 shares during the peApril 28, 2025 | marketbeat.comDiadema Partners LP Makes New Investment in Apogee Therapeutics, Inc. (NASDAQ:APGE)Diadema Partners LP purchased a new position in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 50,620 shares of the company's stock,April 24, 2025 | marketbeat.comCapital World Investors Makes New Investment in Apogee Therapeutics, Inc. (NASDAQ:APGE)Capital World Investors purchased a new stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 205,100 shares of the company's stock, valued at approxApril 24, 2025 | marketbeat.com20,867 Shares in Apogee Therapeutics, Inc. (NASDAQ:APGE) Bought by Jump Financial LLCJump Financial LLC bought a new position in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 20,867 shares of the company's stock, valued at approximately $945,0April 24, 2025 | marketbeat.comFirst Week of APGE June 20th Options TradingApril 24, 2025 | nasdaq.comCompanies Like Apogee Therapeutics (NASDAQ:APGE) Are In A Position To Invest In GrowthApril 23, 2025 | finance.yahoo.comB Group Inc. Buys Shares of 15,000 Apogee Therapeutics, Inc. (NASDAQ:APGE)B Group Inc. acquired a new stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 15,000 shares of the company's stock, valued at approximately $680,000April 23, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Shares Acquired by Barclays PLCBarclays PLC lifted its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 30.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 476,760 shares of the company's stock after acquiring an additional 111,714 shares during the quartApril 22, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Get Free Report) have been given an average rating of "Buy" by the six brokerages that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month target price amApril 20, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Shares Bought by Affinity Asset Advisors LLCAffinity Asset Advisors LLC increased its position in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 40.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 931,728 shares of the company's stApril 17, 2025 | marketbeat.com Get Apogee Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter. Email Address APGE Media Mentions By Week APGE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APGE News Sentiment▼1.590.75▲Average Medical News Sentiment APGE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APGE Articles This Week▼54▲APGE Articles Average Week Get Apogee Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ELAN News Today BPMC News Today BBIO News Today VRNA News Today TLX News Today TGTX News Today GRFS News Today LNTH News Today AXSM News Today NUVL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APGE) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apogee Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apogee Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
